These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28976818)

  • 1. Can harmonized regulation overcome intra-European differences? Insights from a European Phase III stem cell trial.
    Hauskeller C
    Regen Med; 2017 Sep; 12(6):599-609. PubMed ID: 28976818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating regenerative medicine: the Japanese experiment in ethics and regulation.
    Lysaght T
    Regen Med; 2017 Sep; 12(6):657-668. PubMed ID: 28976822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inherent ethical challenge of first-in-human pluripotent stem cell trials.
    Habets MG; van Delden JJ; Bredenoord AL
    Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999
    [No Abstract]   [Full Text] [Related]  

  • 4. Why regenerative stem cell medicine progresses slower than expected.
    Rosemann A
    J Cell Biochem; 2014 Dec; 115(12):2073-6. PubMed ID: 25079695
    [No Abstract]   [Full Text] [Related]  

  • 5. Bridging stem cell research and medicine: a learning health system.
    Touré SB; Kleiderman E; Knoppers BM
    Regen Med; 2018 Sep; 13(6):741-752. PubMed ID: 30043682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials.
    Kleiderman E; Boily A; Hasilo C; Knoppers BM
    Stem Cell Res Ther; 2018 Nov; 9(1):307. PubMed ID: 30409192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Between the Local and the Global:
    Hauskeller C
    Perspect Biol Med; 2018; 61(1):42-58. PubMed ID: 29805147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach.
    Munisi HI; Xie Z; Sengoku S
    Regen Med; 2014; 9(4):467-77. PubMed ID: 25159064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Netherlands advancing to the forefront of regenerative medicine.
    Gielen K
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():29-31. PubMed ID: 25457958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.
    Matthews KR; Iltis AS
    BMC Med Ethics; 2015 Nov; 16(1):75. PubMed ID: 26537611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global challenges in stem cell research and the many roads ahead.
    Sipp D
    Neuron; 2011 May; 70(4):573-6. PubMed ID: 21609815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Situated stem cell ethics: beyond good and bad.
    Liu JA
    Regen Med; 2017 Sep; 12(6):587-591. PubMed ID: 28976823
    [No Abstract]   [Full Text] [Related]  

  • 13. Regenerative medicine in India: trends and challenges in innovation and regulation.
    Tiwari SS; Raman S; Martin P
    Regen Med; 2017 Oct; 12(7):875-885. PubMed ID: 29111891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of stem cells and regenerative medicine research in Argentina.
    Pitossi FJ; Podhajcer OL
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():17-9. PubMed ID: 25457955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1 August-30 September 2015.
    Ilic D
    Regen Med; 2016 Jan; 11(1):11-7. PubMed ID: 26679471
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase III clinical trial using autologous mesenchymal stem cells for stroke patients].
    Honmou O
    Nihon Rinsho; 2016 Apr; 74(4):649-54. PubMed ID: 27333754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of placebos in phase III clinical trials in Brazil.
    Rubenich GB; Heck ST; Hellmann F; Schlemper Junior BR
    Salud Colect; 2015 Mar; 11(1):99-114. PubMed ID: 25853833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative nanomedicine: ethical, legal, and social issues.
    Glenn LM; Boyce JS
    Methods Mol Biol; 2012; 811():303-16. PubMed ID: 22042687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products.
    Bayon Y; Vertès AA; Ronfard V; Culme-Seymour E; Mason C; Stroemer P; Najimi M; Sokal E; Wilson C; Barone J; Aras R; Chiesi A
    Tissue Eng Part B Rev; 2015 Dec; 21(6):560-71. PubMed ID: 26179129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1-31 March 2017.
    Ilic D; Berengueras JM
    Regen Med; 2017 Jul; 12(5):479-486. PubMed ID: 28722542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.